Basic Information
OncoZenge is a Swedish pharmaceutical company established in 2020 through the collaboration of Moberg Pharma and key clinicians from Hvidovre Hospital in Denmark. OncoZenge's vision is to fundamentally improve the quality of life for patients suffering from severe oral pain (e.g., oral pain caused by radiotherapy or cancer chemotherapy).